Sam Waksal
This research page compiles publicly available information about Sam Waksal and their place in the broader Jeffrey Epstein connection graph. People may appear here either because they are mentioned in one or more evidence items (such as flight logs, emails, legal records or credible public reporting), or because reliable public sources document relationships or affiliations that link them to others in this network.
Some profiles therefore track individuals who may be several steps removed — sometimes up to six degrees of separation — from Jeffrey Epstein himself. They are included so researchers can see whether those names later recur in other documents, networks, or investigations. Listing Sam Waksal here is not, by itself, a statement of guilt or innocence.
Use the network graph, shortest-path view, and evidence links below to explore how this person connects to others in the dataset and to Jeffrey Epstein.
Wikipedia Information 
Samuel D. Waksal is the founder and former CEO of the biopharmaceutical company ImClone Systems. He is also the founder of Kadmon Pharmaceuticals, which was financed with private capital and commenced operations in New York City in 2010. At ImClone, Waksal led the company to develop the cancer drug Erbitux (cetuximab). During the course of its review process with the Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members. He was convicted of several securities violations, served time in federal prison, and was released.
- Sam Waksal
- Michael Wolff
- Jeffrey Epstein
Closest Connections
- Michael Wolff — Unknown — Weak
Evidence
- Sam Waksal (Other) 0
Click a name to highlight 1° / 2° / 3° rings. Edge thickness indicates connection strength. Use Tab to focus and arrow keys to navigate.
The presence of Sam Waksal in this dataset should be understood in a research and mapping context only. The project traces publicly documented relationships and degrees of separation — sometimes several steps removed — to see whether particular names recur across different evidence sets over time.
A person may therefore appear here because they are directly mentioned in documents, because they have a publicly reported relationship or affiliation with others in the network, or because they sit several links away in a chain of acquaintances. Inclusion alone does not imply criminal conduct, moral judgment, or endorsement.